Abstract
The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pain management therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pain management therapeutics market on a global level.
In order to give the users of this report a comprehensive view of the pain management therapeutics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein drug class, indication, and distribution channel segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.
The study provides a decisive view of the pain management therapeutics market by segmenting the market based on drug class, indication, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on drug class, the market is segmented into anesthetics, NSAIDS, anticonvulsants, antidepressants, anti-migraine agents, non-narcotic analgesics, opioids (tramadol, oxycodone, hydrocodone, and others). By indication, the market for pain management therapeutics market is segmented as neuropathic pain, arthritic pain, cancer pain, post-operative pain, chronic back pain, fibromyalgia, and migraine. Based on the distribution channel, the market is segmented as hospitals pharmacy, retail pharmacy, and online pharmacy. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of Middle East and Africa. This segmentation includes demand for pain management therapeutics market based on individual drug class, indication, and distribution channel in all the regions and countries.
The report also includes detailed profiles of end players such as Pfizer Inc., Endo International Plc., Depomed, Inc., Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, AstraZeneca plc., Novartis AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline Plc., and Abbott Laboratories, among others
This report segments the global pain management therapeutics market as follows:
Global Pain Management Therapeutics Market: Drug Class Segment Analysis
Anesthetics
NSAIDS
Anticonvulsants
Antidepressants
Anti-migraine agents
Non-narcotic analgesics
Opioids
Tramadol
Oxycodone
Hydrocodone
Others
Global Pain Management Therapeutics Market: Indication Segment Analysis
Neuropathic Pain
Arthritic Pain
Cancer pain
Post-operative Pain
Chronic Back Pain
Fibromyalgia
A migraine
Global Pain Management Therapeutics Market: Distribution Channel Segment Analysis
Hospitals Pharmacy
Retail Pharmacy
Online Pharmacy
Global Pain Management Therapeutics Market: Regional Segment Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa